The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ZEOX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | ZEOX | JRSS | IRWD | BEIGF |
|---|---|---|---|---|
| Moat Score (0–100) | 55 (highest) | 55 (highest) | 55 (highest) | 54 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 27 | 30 | 20 | 80 (highest) |
| Pricing power | 70 | 70 | 99 (highest) | 94 |
| Returns on capital | — | 96 (highest) | 91 | 4 |
| Balance-sheet safety | 78 (highest) | 55 | 30 | 69 |
| Capital allocation | 44 (highest) | 24 | 33 | 24 |
| No price data | 89% below value if growth stopped today (largest discount to value if growth stopped today) | 108% above value if growth stopped today | No price data | |
| Market cap | $7.2M | $1.1M | $580M | Not reported |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2026 | FY2023 | FY2025 | FY2025 |